Special Issue "Nucleoside and Nucleotide Analogues"
Deadline for manuscript submissions: closed (10 July 2017)
Dr. Suzanne Peyrottes
Institut des Biomolécules Max Mousseron (IBMM), Nucleosides & Phosphorylated Effectors Team, UMR 5247 CNRS, Université de Montpellier, ENSCM, Campus Triolet, cc 1705, Place Eugène Bataillon, 34095 Montpellier cedex 5, France
Website | E-Mail
Interests: design and synthesis of potential therapeutic agents to treat infections and cancers, mainly nucleoside and nucleotide analogues; new synthetic methodology related to nucleic acid components
Nucleosides and nucleotides are essential building blocks for nucleic acid biosynthesis and they also play important roles in many biological processes. Since the middle of the last century, they have attracted the interest of chemists for the synthesis of analogues and their derivatives, as well as biochemists and biologists to be used both as tools and/or new drugs. As a consequence, many of them are currently used in clinics.
The current Special Issue aims to bring together all researchers working in the field of nucleosides, nucleotides and their analogues, and to give to them the opportunity to report on their work and recent findings in the related area. Contributions on innovative and emerging synthetic methodologies, synthesis or use of original skeletons, as well as on the broad biological applications of these family of compounds (antiviral, anticancer, antibiotic, antiparasitic, etc.) are welcome.
Dr. Suzanne Peyrottes
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Synthesis of nucleos(t)ide and their analogues, prodrugs, poly(phosphorylated)derivatives;
- Phosphorus chemistry;
- Drug design;
- Nucleos(t)ides as probes or tools
- Medicinal chemistry